Market Cap ₹509 Cr.
Stock P/E 0.0
P/B 7.9
Current Price ₹502
Book Value ₹ 63.3
Face Value 10
52W High ₹550
Dividend Yield 0%
52W Low ₹ 99.9
Shree Tirupati Balajee FIBC Ltd is a leading company specializing in the manufacturing and distribution of Flexible Intermediate Bulk Containers (FIBCs), also known as bulk bags or big bags. Established with a commitment to quality and innovation, the company has emerged as a trusted global player in the packaging industry. Shree Tirupati Balajee FIBC Ltd's product range includes a diverse array of FIBCs tailored to meet the specific needs of various industries, such as agriculture, chemicals, pharmaceuticals, and food. These bags are designed to facilitate safe and efficient storage and transportation of bulk materials, offering cost-effective and environmentally friendly solutions. With a dedication to sustainability and customer satisfaction, Shree Tirupati Balajee FIBC Ltd has earned a reputation for excellence in product quality, reliability, and timely delivery. Their commitment to research and development ensures that they stay at the forefront of FIBC technology, meeting the evolving demands of their clients worldwide.
Price goes above X
Price falls below X
PE goes above X
PE falls below X
₹ | |
| #(Fig in Cr.) |
|---|
| Net Sales |
| Other Income |
| Total Income |
| Total Expenditure |
| Operating Profit |
| Interest |
| Depreciation |
| Exceptional Income / Expenses |
| Profit Before Tax |
| Provision for Tax |
| Profit After Tax |
| Adjustments |
| Profit After Adjustments |
| Adjusted Earnings Per Share |
| #(Fig in Cr.) | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | TTM |
|---|---|---|---|---|---|
| Net Sales | 111 | 117 | 198 | 176 | |
| Other Income | 0 | 0 | 0 | 0 | |
| Total Income | 111 | 117 | 198 | 176 | |
| Total Expenditure | 104 | 108 | 185 | 161 | |
| Operating Profit | 8 | 10 | 13 | 16 | |
| Interest | 2 | 2 | 3 | 3 | |
| Depreciation | 1 | 1 | 1 | 1 | |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | |
| Profit Before Tax | 4 | 6 | 9 | 11 | |
| Provision for Tax | 1 | 2 | 2 | 2 | |
| Profit After Tax | 4 | 5 | 7 | 9 | |
| Adjustments | 0 | 0 | 0 | 0 | |
| Profit After Adjustments | 4 | 5 | 7 | 9 | |
| Adjusted Earnings Per Share | 3.5 | 4.7 | 6.9 | 9.3 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | -11% | 17% | 0% | 0% |
| Operating Profit CAGR | 23% | 26% | 0% | 0% |
| PAT CAGR | 29% | 31% | 0% | 0% |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Share Price CAGR | 275% | 130% | 66% | NA% |
| ROE Average | 16% | 13% | 12% | 12% |
| ROCE Average | 13% | 12% | 11% | 11% |
| #(Fig in Cr.) | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
|---|---|---|---|---|
| Shareholder's Funds | 43 | 48 | 55 | 64 |
| Minority's Interest | 0 | 0 | 0 | 0 |
| Borrowings | 3 | 6 | 12 | 16 |
| Other Non-Current Liabilities | 1 | 2 | 2 | 2 |
| Total Current Liabilities | 34 | 37 | 44 | 36 |
| Total Liabilities | 82 | 92 | 113 | 118 |
| Fixed Assets | 12 | 13 | 16 | 15 |
| Other Non-Current Assets | 12 | 17 | 24 | 27 |
| Total Current Assets | 58 | 62 | 73 | 77 |
| Total Assets | 82 | 92 | 113 | 118 |
| #(Fig in Cr.) | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
|---|---|---|---|---|
| Opening Cash & Cash Equivalents | 1 | 2 | 1 | 2 |
| Cash Flow from Operating Activities | 2 | 1 | 7 | 5 |
| Cash Flow from Investing Activities | -5 | -5 | -11 | -3 |
| Cash Flow from Financing Activities | 4 | 3 | 6 | -4 |
| Net Cash Inflow / Outflow | 1 | -2 | 2 | -2 |
| Closing Cash & Cash Equivalent | 2 | 1 | 2 | 1 |
| # | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
|---|---|---|---|---|
| Earnings Per Share (Rs) | 3.53 | 4.71 | 6.91 | 9.25 |
| CEPS(Rs) | 4.55 | 5.78 | 8.27 | 10.41 |
| DPS(Rs) | 0 | 0 | 0 | 0 |
| Book NAV/Share(Rs) | 42.39 | 47.09 | 54.01 | 63.26 |
| Core EBITDA Margin(%) | 6.7 | 8.13 | 6.34 | 8.82 |
| EBIT Margin(%) | 5.9 | 7.28 | 5.68 | 8.18 |
| Pre Tax Margin(%) | 3.88 | 5.51 | 4.4 | 6.42 |
| PAT Margin (%) | 3.22 | 4.07 | 3.54 | 5.32 |
| Cash Profit Margin (%) | 4.15 | 5 | 4.24 | 5.98 |
| ROA(%) | 4.37 | 5.49 | 6.84 | 8.12 |
| ROE(%) | 8.33 | 10.53 | 13.67 | 15.78 |
| ROCE(%) | 8.64 | 10.46 | 11.81 | 13.43 |
| Receivable days | 32.17 | 38.16 | 38.84 | 45.26 |
| Inventory Days | 76.21 | 86.19 | 63.01 | 79.44 |
| Payable days | 16.68 | 11.87 | 8.46 | 8.46 |
| PER(x) | 6.46 | 8.77 | 10.49 | 18.42 |
| Price/Book(x) | 0.54 | 0.88 | 1.34 | 2.69 |
| Dividend Yield(%) | 0 | 0 | 0 | 0 |
| EV/Net Sales(x) | 0.48 | 0.69 | 0.6 | 1.25 |
| EV/Core EBITDA(x) | 7.09 | 8.41 | 9.46 | 14.09 |
| Net Sales Growth(%) | 0 | 5.44 | 68.85 | -10.88 |
| EBIT Growth(%) | 0 | 30.15 | 31.69 | 28.38 |
| PAT Growth(%) | 0 | 33.37 | 46.76 | 33.86 |
| EPS Growth(%) | 0 | 33.37 | 46.76 | 33.86 |
| Debt/Equity(x) | 0.77 | 0.83 | 0.88 | 0.74 |
| Current Ratio(x) | 1.68 | 1.7 | 1.67 | 2.15 |
| Quick Ratio(x) | 1 | 0.82 | 0.85 | 1.02 |
| Interest Cover(x) | 2.92 | 4.12 | 4.43 | 4.67 |
| Total Debt/Mcap(x) | 1.42 | 0.94 | 0.66 | 0.28 |
| # | Sep 2019 | Mar 2020 | Sep 2020 | Mar 2021 | Sep 2021 | Mar 2022 | Sep 2022 | Mar 2023 | Sep 2023 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 65.7 | 66.41 | 66.73 | 68.63 | 69.49 | 70.88 | 70.88 | 67.12 | 63.85 | 63.85 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Public | 34.3 | 33.59 | 33.27 | 31.37 | 30.51 | 29.12 | 29.12 | 32.88 | 36.15 | 36.15 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Sep 2019 | Mar 2020 | Sep 2020 | Mar 2021 | Sep 2021 | Mar 2022 | Sep 2022 | Mar 2023 | Sep 2023 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 0.67 | 0.67 | 0.68 | 0.7 | 0.7 | 0.72 | 0.72 | 0.68 | 0.65 | 0.65 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Public | 0.35 | 0.34 | 0.34 | 0.32 | 0.31 | 0.29 | 0.29 | 0.33 | 0.37 | 0.37 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1.01 | 1.01 | 1.01 | 1.01 | 1.01 | 1.01 | 1.01 | 1.01 | 1.01 | 1.01 |
Pros
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
| Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
|---|
| Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
|---|
| Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
|---|
| Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
|---|
| Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
|---|
You May Also Know About
